Correlation of clinical and laboratory surrogate markers of immunodepletion with T cell subsets (CD4 & CD8) determined flow cytometrically in HIV infected patients: A hospital based study

Journal of Communicable Diseases

Volumn 35, Issue 3, 2003, Pages 140-153

  Uppal, Sukhbir Singh ^a   Gupta, Salil ^b   Verma, Shashi ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b Command Hospital ^*  (India)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; HEMOGLOBIN;

ARTICLE; CELLULAR IMMUNITY; CLINICAL STUDY; CORRELATION ANALYSIS; FLOW CYTOMETRY; GOVERNMENT; HEMATOLOGICAL PARAMETERS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL PARAMETERS; LABORATORY TEST; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; MAJOR CLINICAL STUDY; REGRESSION ANALYSIS; STATISTICAL ANALYSIS; T LYMPHOCYTE SUBPOPULATION; TUBERCULIN TEST;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIGENS, CD8; BODY WEIGHT; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; FLOW CYTOMETRY; HIV INFECTIONS; HOSPITALS, STATE; HUMANS; INDIA;

EID: 14644442246     PISSN: 00195138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Uppal SS, Verma S and Dhot PS. Normal values of CD4 and CD8 lymphocyte subsets in healthy Indian adults and the effect of gender, age, ethnicity and smoking. Cytometry Part B (Clinical Cytometry) 2003; 52B: 32-36.
2. Rathbun RC. Surrogate markers for assessing treatment response in HIV disease. Ann Pharmacother 1993; 27: 450-455.
3. Ortigao-de-Sampaio MB, Abreu TF, Linhares-de-Carvalho MI, Ponce DL and Castello-Branco LR. Surrogate markers of disease progression in HIV-infected children in Rio de Janeiro, Brazil. J Trop Pediatr 1999; 45: 299-302.
4. Bruisten SM, Frissen PH, Van Swieten P, Harrigan PR, Kinghorn I, Larder B, Weigel HM, De Vries E, Regez RM, Henrichs JH, Koot M and Huisman JG. Prospective longitudinal analysis of viral load and surrogate markers in relation to clinical progression in HIV type 1-infected persons. AIDS Res Hum Retroviruses 1997; 13: 327-335.
5. Schechter M, Zajdenverg R, Machado LL, Pinto ME, Lima LA and Perez MA. Predicting CD4 counts in HIV-infected Brazilian individuals: a model based on the World Health Organization staging system. J Acquir Immune Defic Syndr 1994; 7: 163-168.
6. Niyongabo T, Bouchaud O, Henzel D, Melchior JC, Samb B, Dazza MC, Ruggeri C, Begue JC, Coulaud JP and Larouze B. Nutritional status of HIV-seropositive subjects in an AIDS clinic in Paris. Eur J Clin Nutr 1997; 51: 637-640.
7. Castetbon K, Kadio A, Bondurand A, Boka YA, Barouan C, Coulibaly Y, Anglaret X, Msellati P, Malvy D and Dabis F. Nutritional status and dietary intakes in human immunodeficiency virus (HIV)-infected outpatients in Abidjan. Cote D'Ivoire, 1995. Eur J Clin Nutr 1997; 51: 81-86.
8. Dannhauser A, Van Staden AM, Van der RE, Nel M, Marais N, Erasmus E, Attwood EM, Barnard HC and Le Roux GD. Nutritional status of HIV-1 seropositive patients in the Free State Province of South Africa: anthropometric and dietary profile. Eur J Clin Nutr 1999; 53: 165-173.
9. Luder E, Godfrey E, Godbold J and Simpson DM. Assessment of nutritional, clinical, and immunologic status of HIV- infected, inner-city patients with multiple risk factors. J Am Diet Assoc 1995; 95: 655-660.
10. Sharkey SJ, Sharkey KA, Sutherland LR and Church DL. Nutritional status and food intake in human immunodeficiency virus infection. GI/HIV Study Group. J Acquir Immune Defic Syndr 1992; 5: 1091-1098.
11. Melchior JC, Niyongabo T, Henzel D, Durack-Bown I, Henri SC and Boulier A. Malnutrition and wasting, immunodepression, and chronic inflammation as independent predictors of survival in HIV-infected patients. Nutrition 1999; 15: 865-869.
12. Chlebowski RT, Grosvenor M, Lillington L, Sayre J and Beall G. Dietary intake and counseling, weight maintenance and the course of HIV infection. J Am Diet Assoc 1995; 95: 428-432.
13. Graham NM, Munoz A, Bacellar H, Kingsley LA, Visscher BR and Phair JP. Clinical factors associated with weight loss related to infection with human immunodeficiency virus type 1 in the Multicenter AIDS Cohort Study. Am J Epidemiol 1993; 137: 439-446.
14. Begg MD, Lamster IB, Panageas KS, Mitchell-Lewis D, Phelan JA and Grbic JT. A prospective study of oral lesions and their predictive value for progression of HIV disease. Oral Dis 1997; 3: 176-183.
15. Margiotta V, Campisi G, Mancuso S, Accurso V and Abbadessa V. HIV infection: oral lesions, CD4+ cell count and viral load in an Italian study population. J Oral Pathol Med 1999; 28: 173-177.
16. Ghate MV, Mehendale SM, Mahajan BA, Yadav R, Brahme RG, Divekar AD and Paranjape RS. Relationship between clinical conditions and CD4 counts in HIV-infected persons in Pune, Maharashtra, India. Natl Med J India 2000; 13: 183-187.
17. Ranganathan K, Reddy BV, Kumarasamy N, Solomon S, Viswanathan R and Johnson NW. Oral lesions and conditions associated with human immunodeficiency virus infection in 300 south Indian patients. Oral Dis 2000; 6: 152-157.
18. Chiang CP, Chueh LH, Lin SK and Chen MY. Oral manifestations of human immunodeficiency virus-infected patients in Taiwan. J Formos Med Assoc 1998; 97: 600-605.
19. Phelan JA, Begg MD, Lamster IB, Gorman J, Mitchell-Lewis D, Bucklan RD and el Sadr WM. Oral candidiasis in HIV infection: predictive value and comparison of findings in injecting drug users and homosexual men. J Oral Pathol Med 1997; 26: 237-243.
20. Wadia RS, Pujari SN, Kothari S, Udhar M, Kulkarni S, Bhagat S and Nanivadekar A. Neurological manifestations of HIV disease. J Assoc Physicians India 2001; 49: 343-348.
21. Kumarasamy N, Solomon S, Madhivanan P, Ravikumar B, Thyagarajan SP and Yesudian P. Dermatologic manifestations among human immunodeficiency virus patients in south India. Int J Dermatol 2000; 39: 192-195.
22. Buchbinder SP, Katz MH, Hessol NA, Liu JY, O'Malley PM, Underwood R and Holmberg SD. Herpes zoster and human immunodeficiency virus infection. J Infect Dis 1992; 166: 1153-1156.
23. Veenstra J, Krol A, Van Praag RM, Frissen PH, Schellekens PT, Lange JM, Coutinho RA and Van der Meer JT. Herpes zoster, immunological deterioration and disease progression in HIV-1 infection. AIDS 1995; 9: 1153-1158.
24. Powderly WG, Finkelstein D, Feinberg J, Frame P, He W, Van der HC, Koletar SL, Eyster ME, Carey J and Waskin H. A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. N Engl J Med 1995; 332: 700-705.
25. Moore RD and Chaisson RE. Natural history of opportunistic disease in an HIV-infected urban clinical cohort. Ann Intern Med 1996; 124: 633-642.
26. Malkin JE, Prazuck T, Simonnet F, Yameogo M, Rochereau A, Ayeroue J, Masson D and Lafaix C. Tuberculosis and human immunodeficiency virus infection in west Burkina Faso: clinical presentation and clinical evolution. Int J Tuber Lung Dis 1997; 1: 68-74.
27. Ackah AN, Coulibaly D, Digbeu H, Diallo K, Vetter KM, Coulibaly IM, Greenberg AE and De Cock KM. Response to treatment, mortality, and CD4 lymphocyte counts in HIV- infected persons with tuberculosis in Abidjan, Cote d'Ivoire. Lancet 1995; 345: 607-610.
28. Sharma SK, Mohan A, Gupta R, Kumar A, Gupta AK, Singhal VK and Pande JN. Clinical presentation of tuberculosis in patients with AIDS: an Indian experience. Indian J Chest Dis Allied Sci 1997; 39: 213-220.
29. Mocroft A, Kirk O, Barton SE, Dietrich M, Proenca R, Colebunders R, Pradier C, dArminio MA, Ledergerber B and Lundgren JD. Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. Euro SIDA study group. AIDS 1999; 13: 943-950.
30. Sullivan PS, Hanson DL, Chu SY, Jones JL and Ward JW. Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: results from the multistate adult and adolescent spectrum of HIV disease surveillance project. Blood 1998; 91: 301-308.
31. Zon LI and Groopman JE. Hematologic manifestations of the human immune deficiency virus (HIV). Semin Hematol 1988; 25: 208-218.
32. Beck EJ, Kupek EJ, Gompels MM and Pinching AJ. Correlation between total and CD4 lymphocyte counts in HIV infection: not making the good an enemy of the not so perfect. Int J STD AIDS 1996; 7: 422-428.
33. Sloan P, Carlin J and Crowe SM. Total lymphocyte count can predict low CD4: a useful subset for T cell analysis (Abstract WB 2409). Programme and abstract of VIIth International Conference on AIDS 1994; 8: 73-79.
34. Blatt SP, Lucey CR, Butzin CA, Hendrix CW and Lucey DR. Total lymphocyte count as a predictor of absolute CD4+ count and CD4+ percentage in HIV-infected persons. JAMA 1993; 269: 622-626.
35. Martin DJ, Sim JG, Sole GJ, Rymer L, Shalekoff S, Van Niekerk AB, Becker P, Weilbach CN, Iwanik J and Keddy K. CD4+ lymphocyte count in African patients co-infected with HIV and tuberculosis. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8: 386-391.
36. Pascale JM, Isaacs MD, Contreras P, Gomez B, Lozano L, Austin E, De Martin MC, Gregory RL, McLaughlin GL and Amador A. Immunological markers of disease progression in patients infected with the human immunodeficiency virus. Clin Diagn Lab Immunol 1997; 4: 474-477.
37. Kaushik P and Richa Kaushik. Usefulness of total lymphocyte count as a surrogate estimation of suspected AIDS. J Assoc Physicians India 1997; 45: 455-456.
38. Galli M, Musicco M, Gervasoni C, Ridolfo AL, Niero F, Rusconi S, Riva A, Voltolin L, Lupo A, Lovicu GF, Radice D and Moroni M. No evidence of a higher risk of progression to AIDS in patients with HIV-1 related severe thrombocytopenia. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 12: 268-275.
39. Sullivan PS, Hanson DL, Chu SY, Jones JL and Ciesielski CA. Surveillance for thrombocytopenia in persons infected with HIV: results from the multistate Adult and Adolescent Spectrum of Disease Project. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14: 374-379.
40. Moreno S, Baraia-Etxaburu J, Bouza E, Parras F, Perez-Tascon M, Miralles P, Vicente T, Alberdi JC, Cosin J and Lopez-Gay D. Risk for developing tuberculosis among anergic patients infected with HIV. Ann Intern Med 1993; 119: 194-198.
41. Khoo SH, Wilkins EG, Fraser IS, Hamour AA and Stanford JL. Lack of skin test reactivity to common mycobacterial antigens in human immunodeficiency virus infected individuals with high CD4 counts. Thorax 1996; 51: 932-935.
42. Janis EM, Allen DW, Glesby MJ, Carey LA, Mundy LM, Gopalan R and Chaisson RE. Tuberculin skin test reactivity, anergy, and HIV infection in hospitalized patients. Longcope Firm of the Osler Medical Housestaff. Am J Med 1996; 100: 186-192.
43. Blatt SP, Hendrix CW, Butzin CA, Freeman TM, Ward WW, Hensley RE, Melcher GP, Donovan DJ and Boswell RN. Delayed-type hypersensitivity skin testing predicts progression to AIDS in HIV-infected patients. Ann Intern Med 1993; 119: 177-184.
44. Bem C. Human immunodeficiency virus-positive tuberculous lymphadenitis in Central Africa: clinical presentation of 157 cases. Int J Tuberc Lung Dis 1997; 1: 215-219.
45. Ullum H, Lepri AC, Katzenstein TL, Phillips AN, Skinhoj P, Gerstoft J and Pedersen BK. Prognostic value of single measurements of beta-2-microglobulin, immunoglobulin A in HIV disease after controlling for CD4 lymphocyte counts and plasma HIV RNA levels. Scand J Infect Dis 2000; 32: 371-376.
46. Hofmann B, Wang YX, Cumberland WG, Detels R, Bozorgmehri M and Fahey JL. Serum beta 2-microglobulin level increases in HIV infection: relation to seroconversion, CD4 T-cell fall and prognosis. AIDS 1990; 4: 207-214.
47. Lawn SD, Rudolph D, Wiktor S, Coulibaly D, Ackah A and Lal RB. Tuberculosis (TB) and HIV infection are independently associated with elevated serum concentrations of tumour necrosis factor receptor type 1 and beta2-microglobulin, respectively. Clin Exp Immunol 2000; 122: 79-84.
48. Mocroft A, Johnson MA, Sabin CA, Bofill M, Janossy G and Phillips AN. The relationship between beta-2-microglobulin, CD4 lymphocyte count. AIDS and death in HIV-positive individuals. Epidemiol Infect 1997; 118: 259-266.
49. O'Brien WA, Hartigan PM, Martin D, Esinhart J, Hill A, Benoit S, Rubin M, Simberkoff MS and Hamilton JD. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. N Engl J Med 1996; 334: 426-431.
50. Mellors JW, Munoz A, Giorgi JV, Margolick JB, Tassoni CJ, Gupta P, Kingsley LA, Todd JA, Saah AJ, Detels R, Phair JP and Rinaldo CR. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med Jr 1997; 126: 946-954.